Successful Administration of Recombinant Human Soluble Thrombomodulin α (Recomodulin) for Disseminated Intravascular Coagulation during Induction Chemotherapy in an Elderly Patient with Acute Monoblastic Leukemia Involving the t(9;11)(p22;q23) MLL/AF9 Translocation
Case Reports in Hematology · 2011
DOI: 10.1155/2011/273070 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Hematology, 2011. Verfasst von Kazutaka Takagi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, Matsuoka Shimoaizuki 23, Eiheiji, Fukui 910-1193, Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Patients with acute myelogenous leukemia complicate with disseminated intravascular coagulation (DIC), not only at the time of the initially leukemia diagnosis, but also during induction chemotherapy. In Japan, recently, a recombinant human soluble thrombomodulin alpha (Recomodulin) has been introduced as a new type of anti-DIC agent for clinical use in patients with hematological cancer or infectious disease. We describe a 67-year-old female case in which 25,600 units of Recomodulin for 6 days were successfully administered for both initially complicating and therapy-induced DIC without any troubles of bleeding in an acute monoblastic leukemia (AML-M5a) patient with the MLL gene translocation. Furthermore, the levels of DIC biomarkers recovered rapidly after the Recomodulin treatment. Our case suggests that DIC control using Recomodulin is one of the crucial support-therapies during remission induction chemotherapy in patients with acute leukemia of which type tends to complicate extramedullary or extranodal infiltration having potential to onset DIC.
Autor:innen und Institutionen
- Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, Matsuoka Shimoaizuki 23, Eiheiji, Fukui 910-1193, Japan.
Zitieren
APA
Takagi, K., Tasaki, T., Yamauchi, T., Iwasaki, H., & Ueda, T. (2011). Successful Administration of Recombinant Human Soluble Thrombomodulin α (Recomodulin) for Disseminated Intravascular Coagulation during Induction Chemotherapy in an Elderly Patient with Acute Monoblastic Leukemia Involving the t(9;11)(p22;q23) MLL/AF9 Translocation. Case Reports in Hematology. https://doi.org/10.1155/2011/273070
Vancouver
Takagi K, Tasaki T, Yamauchi T, Iwasaki H, Ueda T. Successful Administration of Recombinant Human Soluble Thrombomodulin α (Recomodulin) for Disseminated Intravascular Coagulation during Induction Chemotherapy in an Elderly Patient with Acute Monoblastic Leukemia Involving the t(9;11)(p22;q23) MLL/AF9 Translocation. Case Reports in Hematology. 2011. doi:10.1155/2011/273070
BibTeX
@article{Takagi2011,
author = {Takagi, Kazutaka and Tasaki, Toshiki and Yamauchi, Takahiro and Iwasaki, Hiromichi and Ueda, Takanori},
title = {Successful Administration of Recombinant Human Soluble Thrombomodulin α (Recomodulin) for Disseminated Intravascular Coagulation during Induction Chemotherapy in an Elderly Patient with Acute Monoblastic Leukemia Involving the t(9;11)(p22;q23) MLL/AF9 Translocation},
journal = {Case Reports in Hematology},
year = {2011},
doi = {10.1155/2011/273070}
}
EUVIMED